What does Goldbell Group invest in?
Goldbell Group invests most often at Series B and Series C (65% of the rounds on record), in sectors such as Health Care, Social and Consumer Goods.
Singapore · Investor
Last cheque observed Oct 2025. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.
QuietGrowth equityWebsite unconfirmed
Follow Goldbell Group and see its new cheques in your feed.Start following
Another investor of this name exists, and we could not establish from the rounds which of them the press meant. Treat the record below as possibly belonging to either. Tell us which if you know.
24 rounds on record
Mostly Series B and Series C: 65% of its rounds
A website was listed for this organisation, but we could not confirm it belongs to the firm that wrote these cheques. Either the site never mentions them, or it turned out to be a different company sharing the name. We show neither it nor anything read from it. Tell us the right one.
Every round we can evidence, newest first24 appearances
1 round
3 rounds
11 rounds
9 rounds
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
From their own portfolio page (on their website)
PilonSWAT MobilityXsquaretechnologiesBlueSGEmmasgFinancingGbcare
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as Goldbell Group. A count of rooms they were both in, not a relationship either has claimed.
The latest companies Goldbell Group put money into.
Goldbell Group invests most often at Series B and Series C (65% of the rounds on record), in sectors such as Health Care, Social and Consumer Goods.
24 investments on record, 0 of them in the last 12 months. The most recent was in Oct 2025.
Its most recent investments on record: Takenos (Seed, Oct 2025), Waycare (Series A, Oct 2019) and Faraday Pharmaceuticals (Undisclosed round, Sept 2019).
The median round it joins is $38M.
Rarely, if at all: none of its 24 investments on record names it as the lead.
Most of the companies it backs are in the United States (92%).
No investments in the last 12 months; the latest was in Oct 2025.
Most often Alexandria Real Estate Equities (5 rounds together), Arch (3 rounds together) and Illumina (3 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it